Getinge Dirección

Dirección controles de criterios 3/4

El CEO de Getinge's es Mattias Perjos , nombrado en Mar 2017, tiene una permanencia de 7.08 años. compensación anual total es SEK46.39M, compuesta por 55.9% salario y 44.1% primas, incluidas acciones y opciones de la empresa. posee directamente un 0.029% de las acciones de la empresa, por valor de SEK18.58M. La antigüedad media del equipo directivo y de la junta directiva es de 4.5 años y 7.1 años, respectivamente.

Información clave

Mattias Perjos

Chief Executive Officer (CEO)

kr46.4m

Compensación total

Porcentaje del salario del CEO	55.9%
Permanencia del CEO	7.2yrs
Participación del CEO	0.03%
Permanencia media de la dirección	4.5yrs
Promedio de permanencia en la Junta Directiva	7.2yrs

Actualizaciones recientes de la dirección

Recent updates

Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Apr 25

Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?

Apr 15

The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts

Mar 30

Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's

Mar 29

The Return Trends At Getinge (STO:GETI B) Look Promising

Mar 21

Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results

Feb 04

There's Reason For Concern Over Getinge AB (publ)'s (STO:GETI B) Price

Jan 20

Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly

Jan 05

Getinge AB (publ)'s (STO:GETI B) Intrinsic Value Is Potentially 42% Above Its Share Price

Dec 20

Returns On Capital Are Showing Encouraging Signs At Getinge (STO:GETI B)

Dec 05

Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet

Oct 06

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 37% Undervaluation?

Sep 21

Getinge's (STO:GETI B) Returns On Capital Are Heading Higher

Sep 03

Is Getinge (STO:GETI B) A Risky Investment?

Jun 28

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 23% Undervaluation?

Jun 15

Investors Will Want Getinge's (STO:GETI B) Growth In ROCE To Persist

Jun 01

At kr252, Is Getinge AB (publ) (STO:GETI B) Worth Looking At Closely?

May 05

Getinge (STO:GETI B) Has Announced That It Will Be Increasing Its Dividend To SEK4.25

Apr 05

Slowing Rates Of Return At Getinge (STO:GETI B) Leave Little Room For Excitement

Feb 28

Análisis de compensación del CEO

¿Cómo ha cambiado la remuneración de Mattias Perjos en comparación con los beneficios de Getinge?
Fecha	Compensación total	Salario	Ingresos de la empresa
Mar 31 2024	n/a	n/a	kr2b
Dec 31 2023	kr46m	kr26m	kr2b
Sep 30 2023	n/a	n/a	kr2b
Jun 30 2023	n/a	n/a	kr2b
Mar 31 2023	n/a	n/a	kr3b
Dec 31 2022	kr43m	kr24m	kr2b
Sep 30 2022	n/a	n/a	kr3b
Jun 30 2022	n/a	n/a	kr3b
Mar 31 2022	n/a	n/a	kr3b
Dec 31 2021	kr60m	kr23m	kr3b
Sep 30 2021	n/a	n/a	kr3b
Jun 30 2021	n/a	n/a	kr4b
Mar 31 2021	n/a	n/a	kr4b
Dec 31 2020	kr67m	kr23m	kr3b
Sep 30 2020	n/a	n/a	kr3b
Jun 30 2020	n/a	n/a	kr2b
Mar 31 2020	n/a	n/a	kr1b
Dec 31 2019	kr46m	kr22m	kr1b
Sep 30 2019	n/a	n/a	kr1b
Jun 30 2019	n/a	n/a	-kr632m
Mar 31 2019	n/a	n/a	-kr654m
Dec 31 2018	kr34m	kr21m	-kr967m
Sep 30 2018	n/a	n/a	-kr727m
Jun 30 2018	n/a	n/a	kr847m
Mar 31 2018	n/a	n/a	kr676m
Dec 31 2017	kr26m	kr15m	kr1b

Compensación vs. Mercado: La compensación total de Mattias($USD4.27M) está por encima de la media de empresas de tamaño similar en el mercado Swedish ($USD2.33M).

Compensación vs. Ingresos: La compensación de Mattias ha sido consistente con los resultados de la empresa en el último año.

CEO

Mattias Perjos (51 yo)

7.2yrs

Permanencia

kr46,388,000

Compensación

Mr. Mattias Perjos, M. Sc., serves as Independent Director at Euroapi S. A. since January 11, 2023. He has been the Chief Executive Officer and President at Getinge AB since March 27, 2017. Mr. Perjos serv...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Mattias Perjos	CEO, President & Director	7.2yrs	kr46.39m	0.029% SEK 18.8m
Agneta Palmer	Chief Financial Officer	less than a year	sin datos	sin datos
Lars Mattsson	Head of Investor Relations	no data	sin datos	sin datos
Anna Romberg	Executive Vice President of Sustainability	3.6yrs	sin datos	0.0020% SEK 1.3m
Magnus Lundback	Executive Vice President of Human Resources	7.3yrs	sin datos	0.0014% SEK 902.5k
Carsten Blecker	Chief Commercial Officer	6.4yrs	sin datos	0.0018% SEK 1.2m
Stephane Roy	President of Surgical Workflows	5.5yrs	sin datos	0.0014% SEK 896.1k
Eric Honroth	President of Life Science	no data	sin datos	0.000060% SEK 38.4k
Patricia Fitch	President of North America Region	2.1yrs	sin datos	sin datos
Elin Frostehav	President of Acute Care Therapies	2.1yrs	sin datos	0.00032% SEK 204.8k
Joanna Engelke	Executive VP of Quality Compliance	1.6yrs	sin datos	sin datos
Avril Forde	President of Maquet Ltd & Maquet Ireland	8.3yrs	sin datos	sin datos

4.5yrs

Permanencia media

51yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de GETI B se considera experimentado (4.5 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Mattias Perjos	CEO, President & Director	7.2yrs	kr46.39m	0.029% SEK 18.8m
Johan Bygge	Independent Director	17.1yrs	kr972.90k	0.0058% SEK 3.7m
Carl Bennet	Non-Independent Vice Chairman	35.3yrs	kr781.43k	sin datos
Malin Persson	Independent Director	10.3yrs	kr781.43k	0.0030% SEK 1.9m
Johan Malmquist	Independent Chairman	8.2yrs	kr1.73m	0.037% SEK 23.5m
Cecilia Wennborg	Independent Director	14.1yrs	kr969.80k	0.0029% SEK 1.9m
Ake Larsson	Employee Representative Director	1.6yrs	sin datos	sin datos
Dan Frohm	Non-Independent Director	7.2yrs	kr928.40k	0.055% SEK 35.1m
Fredrik Brattborn	Employee Representative Director	2.1yrs	sin datos	sin datos
Kristian Samuelsson	Independent Director	3.1yrs	kr819.72k	sin datos
Pontus Kall	Deputy Director	no data	sin datos	sin datos
Ida Gustafsson	Deputy Director	1.6yrs	sin datos	0.000020% SEK 12.8k

7.2yrs

Permanencia media

53yo

Promedio de edad

Junta con experiencia: La junta directiva de GETI B se considera experimentada (7.1 años de antigüedad promedio).

Getinge Dirección

Dirección controles de criterios 3/4

Información clave

Actualizaciones recientes de la dirección

Getinge Announces CFO Changes

Getinge AB (Publ) Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023

Getinge AB (Publ) Announces Executive Changes

Getinge AB (Publ) Appoints Joanna Engelke as New Executive Vice President Quality Compliance, Regulatory & Medical Affairs and Member of the Getinge Executive Team

Getinge Appoints Agneta Palmér as Executive Vice President Operational Services Member of the Getinge Executive Team

Lena Hagman to Leave Getinge AB (publ) as Executive Vice President Quality Compliance, Regulatory & Medical Affairs

Recent updates

Results: Getinge AB (publ) Exceeded Expectations And The Consensus Has Updated Its Estimates

Getinge AB (publ) Declares A Dividend, Payable on 29 April 2024

Upcoming dividend of kr4.40 per share

Is Getinge AB (publ) (STO:GETI B) Trading At A 41% Discount?

The Getinge AB (publ) (STO:GETI B) Annual Results Are Out And Analysts Have Published New Forecasts

Getinge's (STO:GETI B) Upcoming Dividend Will Be Larger Than Last Year's

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Getinge AB (publ) to Report Fiscal Year 2024 Results on Jan 28, 2025

The Return Trends At Getinge (STO:GETI B) Look Promising

Dividend increased to kr4.40

Getinge AB (publ) to Report Fiscal Year 2023 Final Results on Mar 27, 2024

Getinge AB (Publ) Proposes Dividend, Payable on April 29, 2024

Getinge Takes A Leap Forward in Cardiovascular Surgery with the 510(k) Clearance for Vasoview Hemopro 3

Analysts Are Updating Their Getinge AB (publ) (STO:GETI B) Estimates After Its Full-Year Results

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Getinge AB (Publ) Provides Sales Guidance for the Year 2024

Getinge Announces CFO Changes

There's Reason For Concern Over Getinge AB (publ)'s (STO:GETI B) Price

Here's Why Getinge (STO:GETI B) Can Manage Its Debt Responsibly

Price target increased by 8.4% to kr229

Getinge AB (publ)'s (STO:GETI B) Intrinsic Value Is Potentially 42% Above Its Share Price

Returns On Capital Are Showing Encouraging Signs At Getinge (STO:GETI B)

Price target increased by 7.0% to kr220

Consensus EPS estimates increase by 23%

Third quarter 2023 earnings: Revenues exceed analyst expectations

Getinge AB (publ) (OM:GETI B) acquired Healthmark Industries Company, Inc. for $320 million.

Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 37% Undervaluation?

Getinge AB (Publ) Announces Resignation of Jeanette Hedén Carlsson as Executive Vice President Brand & Communication, Effective December 31, 2023

Getinge's (STO:GETI B) Returns On Capital Are Heading Higher

Second quarter 2023 earnings: Revenues exceed analyst expectations

Getinge Receives US FDA 510(K) Clearance for Servo-Air® Lite

Is Getinge (STO:GETI B) A Risky Investment?

Consensus EPS estimates fall by 13%

Investor sentiment deteriorates as stock falls 22%

Is There An Opportunity With Getinge AB (publ)'s (STO:GETI B) 23% Undervaluation?

Getinge AB (publ) (OM:GETI B) entered into an agreement to acquire High Purity New England Inc. for approximately $290 million.

Investors Will Want Getinge's (STO:GETI B) Growth In ROCE To Persist

At kr252, Is Getinge AB (publ) (STO:GETI B) Worth Looking At Closely?

First quarter 2023 earnings: Revenues exceed analyst expectations

Now 22% undervalued

Upcoming dividend of kr4.25 per share at 1.6% yield

Getinge (STO:GETI B) Has Announced That It Will Be Increasing Its Dividend To SEK4.25

Slowing Rates Of Return At Getinge (STO:GETI B) Leave Little Room For Excitement

Is Getinge AB (publ) (STO:GETI B) Trading At A 42% Discount?

Getinge (STO:GETI B) Is Paying Out A Larger Dividend Than Last Year

Getinge Provides Financial Guidance for the First Half, Second Half and Full Year of 2023

Is Getinge (STO:GETI B) Using Too Much Debt?

Full year 2022 earnings: EPS misses analyst expectations

Getinge AB (Publ) Proposes Dividend

Price target decreased to kr249

When Should You Buy Getinge AB (publ) (STO:GETI B)?

Price target decreased to kr272

U.S. Food and Drug Administration Broadens the Consent Decree with Getinge and Includes Its Subsidiary Datascope

Are Investors Undervaluing Getinge AB (publ) (STO:GETI B) By 49%?

Third quarter 2022 earnings: Revenues in line with analyst expectations

Getinge AB (publ) Provides Sales Guidance for the Full Year 2022

Getinge AB (Publ) Announces Executive Changes

Getinge (STO:GETI B) Has A Pretty Healthy Balance Sheet

Getinge AB (Publ) Appoints Joanna Engelke as New Executive Vice President Quality Compliance, Regulatory & Medical Affairs and Member of the Getinge Executive Team

Price target decreased to kr293

Getinge AB (Publ) Announces Medical Device Field Action of Hls Set Advanced Products

Second quarter 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Getinge Appoints Agneta Palmér as Executive Vice President Operational Services Member of the Getinge Executive Team

Price target decreased to kr344

Getinge AB (publ) to Report Q2, 2022 Results on Jul 19, 2022

Lena Hagman to Leave Getinge AB (publ) as Executive Vice President Quality Compliance, Regulatory & Medical Affairs

We Think Getinge (STO:GETI B) Can Stay On Top Of Its Debt

Price target decreased to kr386